In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001202:Ascitic Fluid / Q000382:microbiology; D002437:Cefazolin / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology*; D006020:Glycopeptides / Q000494:pharmacology; D006801:Humans; D010068:Oxacillin / Q000494:pharmacology; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects*; D013212:Staphylococcus epidermidis / Q000187:drug effects; D017334:Teicoplanin; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D002939:Ciprofloxacin; D017334:Teicoplanin; D014640:Vancomycin; D002437:Cefazolin; D010068:Oxacillin